Fresenius Medical Care (FMS) Competitors $21.79 -0.31 (-1.40%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends FMS vs. NTRA, HIMS, SHC, GH, OPCH, BTSG, VCYT, SGRY, LFST, and PACSShould you be buying Fresenius Medical Care stock or one of its competitors? The main competitors of Fresenius Medical Care include Natera (NTRA), Hims & Hers Health (HIMS), Sotera Health (SHC), Guardant Health (GH), Option Care Health (OPCH), BrightSpring Health Services (BTSG), Veracyte (VCYT), Surgery Partners (SGRY), LifeStance Health Group (LFST), and PACS Group (PACS). These companies are all part of the "healthcare" industry. Fresenius Medical Care vs. Natera Hims & Hers Health Sotera Health Guardant Health Option Care Health BrightSpring Health Services Veracyte Surgery Partners LifeStance Health Group PACS Group Fresenius Medical Care (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends, valuation and community ranking. Do insiders and institutionals hold more shares of FMS or NTRA? 8.3% of Fresenius Medical Care shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 7.6% of Natera shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer FMS or NTRA? Natera received 58 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.78% of users gave Natera an outperform vote while only 54.69% of users gave Fresenius Medical Care an outperform vote. CompanyUnderperformOutperformFresenius Medical CareOutperform Votes42054.69% Underperform Votes34845.31% NateraOutperform Votes47868.78% Underperform Votes21731.22% Is FMS or NTRA more profitable? Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Fresenius Medical Care3.43% 6.04% 2.69% Natera -14.01%-26.23%-14.27% Which has more volatility and risk, FMS or NTRA? Fresenius Medical Care has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, Natera has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500. Does the media refer more to FMS or NTRA? In the previous week, Natera had 23 more articles in the media than Fresenius Medical Care. MarketBeat recorded 26 mentions for Natera and 3 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.46 beat Natera's score of 0.82 indicating that Fresenius Medical Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 15 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer FMS or NTRA? Fresenius Medical Care currently has a consensus price target of $24.30, indicating a potential upside of 11.52%. Natera has a consensus price target of $140.59, indicating a potential downside of 16.26%. Given Fresenius Medical Care's higher probable upside, analysts clearly believe Fresenius Medical Care is more favorable than Natera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresenius Medical Care 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Natera 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings & valuation, FMS or NTRA? Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresenius Medical Care$21.05B0.61$540.07M$1.2118.01Natera$1.08B20.47-$434.80M-$1.76-95.39 SummaryFresenius Medical Care and Natera tied by winning 9 of the 18 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get Fresenius Medical Care News Delivered to You Automatically Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FMS vs. The Competition Export to ExcelMetricFresenius Medical Carehealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$12.79B$2.02B$5.05B$19.87BDividend Yield2.00%6.93%5.17%3.54%P/E Ratio18.0115.72125.6942.87Price / Sales0.615.761,179.7818.11Price / Cash4.8011.3633.7717.86Price / Book0.803.274.685.52Net Income$540.07M$69.56M$119.54M$986.45M7 Day Performance3.47%-0.03%-2.46%-0.22%1 Month Performance6.29%2.88%-4.08%0.12%1 Year Performance11.12%-12.30%29.82%23.71% Fresenius Medical Care Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FMSFresenius Medical Care3.9521 of 5 stars$21.79-1.4%$24.30+11.5%+11.1%$12.97B$21.05B18.011,358Positive NewsNTRANatera2.8052 of 5 stars$167.88+3.6%$140.59-16.3%+206.4%$21.40B$1.08B0.003,293Analyst ForecastHIMSHims & Hers Health3.5694 of 5 stars$21.80-7.4%$20.71-5.0%+181.8%$5.14B$872M49.551,046Analyst ForecastInsider TradeSHCSotera Health3.6657 of 5 stars$13.21-2.9%$16.50+24.9%-5.2%$3.85B$1.05B52.843,000High Trading VolumeGHGuardant Health4.2853 of 5 stars$30.68flat$40.60+32.3%+28.4%$3.79B$563.95M0.001,779OPCHOption Care Health4.9784 of 5 stars$21.88+0.3%$30.83+40.9%-26.3%$3.71B$4.30B18.397,802Positive NewsBTSGBrightSpring Health Services2.9593 of 5 stars$18.79+0.8%$16.79-10.6%N/A$3.25B$8.83B0.0035,000Positive NewsVCYTVeracyte4.1264 of 5 stars$39.20+0.1%$41.25+5.2%+50.5%$3.03B$361.05M-261.33790Analyst ForecastSGRYSurgery Partners3.0975 of 5 stars$22.51-1.1%$38.71+72.0%-29.9%$2.89B$2.74B-46.9013,500Analyst ForecastLFSTLifeStance Health Group1.7849 of 5 stars$7.22-0.3%$8.50+17.7%+16.5%$2.77B$1.06B0.009,325PACSPACS Group4.0685 of 5 stars$17.25+0.9%$39.88+131.2%N/A$2.61B$3.11B0.0032,433Analyst Forecast Related Companies and Tools Related Companies NTRA Competitors HIMS Competitors SHC Competitors GH Competitors OPCH Competitors BTSG Competitors VCYT Competitors SGRY Competitors LFST Competitors PACS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:FMS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius Medical Care AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius Medical Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
